(Q41683229)

7 October 2017

title

Use of ribozymes to inhibit gene expression (English)

1 reference

7 October 2017

0 references

3

Wong-Staal F

1 reference

7 October 2017

Krüger M

1

1 reference

7 October 2017

Beger C

series ordinal

2

1 reference

7 October 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

7 October 2017

published in

Methods in Enzymology

1 reference

7 October 2017

volume

306

1 reference

7 October 2017

page(s)

207-225

1 reference

Gene therapy -- promises, problems and prospects

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906014-0

7 January 2021

Mutagenesis of the hairpin ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906014-0

7 January 2021

[21] Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906014-0

7 January 2021

Chimeric DNA-RNA hammerhead ribozyme to proliferating cell nuclear antigen reduces stent-induced stenosis in a porcine coronary model

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906014-0

7 January 2021

The structure, function and application of the hammerhead ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906014-0

7 January 2021

Evaluation of the efficacy and safety of in vitro, adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906014-0

7 January 2021

Ribozymes as potential anti-HIV-1 therapeutic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906014-0

7 January 2021

In vitro and in vivo characterization of a second functional hairpin ribozyme against HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906014-0

7 January 2021

Activity and cleavage site specificity of an anti-HIV-1 hairpin ribozyme in human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906014-0

7 January 2021

Transfer of an anti-HIV-1 ribozyme gene into primary human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906014-0

7 January 2021

A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906014-0

7 January 2021

A chimeric human immunodeficiency virus type 1 (HIV-1) minimal Rev response element-ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2899%2906014-0

7 January 2021

10.1016/S0076-6879(99)06014-0

Identifiers

DOI

1 reference

7 October 2017

1 reference